Exchange Traded Funds (ETFs) are a relatively new financial product that has experienced significant growth in the last few years. Leveraged, inverse, and inverse leveraged ETFs—new ETF structures that have become available over the last several years—have recently become the target of regulatory investigations and litigation. This article provides an introduction to ETFs in the context of recent regulatory problems and litigation.
Aggregate royalty for cellular SEPs in recent court decisions
This academic paper, “Aggregate Royalty for Cellular SEPs in Recent Court Decisions,” published in GRUR Patent by CRA Competition experts Nadia Soboleva and...